Correlation between the formation of cleavable complex with topoisomerase I and growth-inhibitory activity for saintopin-type antibiotics.

New saintopin-type antibiotics (e.g., saintopin, saintopin E, UCE1022, UCE6) with a naphthacene-dione structure have been discovered through our mechanistically oriented screening using purified mammalian DNA topoisomerases. Saintopin is a dual inducer of topoisomerase I- and topoisomerase II-mediated DNA cleavages in a cell-free system using purified enzymes, whereas others induced topoisomerase I- but not topoisomerase II-mediated DNA cleavage. The order of topoisomerase I-mediated DNA cleavage activity at lower concentrations (<1 microM) was UCE6 > saintopin > saintopin E > UCE1022. The DNA cleavage-intensity patterns induced by these antibiotics with topoisomerase I were identical, indicating that saintopin-type antibiotics have a similar DNA sequence selectivity in stabilization of the cleavable complex with topoisomerase I. Increases in protein/DNA complexes were observed in saintopin-type antibiotic-treated HeLa S3 cells using the potassium/sodium dodecyl sulfate precipitation method. Brief heating of these drugs-treated cells at 65 degrees for 10 min resulted in a rapid reduction in the number of protein/DNA complexes. Immunoblot analysis using antibody against human topoisomerase I or II revealed that the protein linked to DNA in saintopin-type antibiotic-treated cells is most likely topoisomerase I. These results suggest that saintopin-type antibiotics interfere with topoisomerase I in cells by trapping reversible topoisomerase I/DNA cleavable complexes. The formation of topoisomerase I/DNA complexes by saintopin-type antibiotics correlates well with their growth-inhibitory activities, suggesting that topoisomerase I can be the principal target of these antibiotics.

[1]  K. Kohno,et al.  Drug-induced down-regulation of topoisomerase I in human epidermoid cancer cells resistant to saintopin and camptothecins. , 1996, Cancer research.

[2]  Y. Pommier,et al.  Saintopin, a dual inhibitor of DNA topoisomerases I and II, as a probe for drug-enzyme interactions. , 1994, The Journal of biological chemistry.

[3]  F. Zunino,et al.  Unique sequence specificity of topoisomerase II DNA cleavage stimulation and DNA binding mode of streptonigrin. , 1994, The Journal of biological chemistry.

[4]  J. Mohler,et al.  Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. , 1994, Cancer research.

[5]  H. Nakano,et al.  UCE1022, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from Paecilomyces. , 1993, The Journal of antibiotics.

[6]  H. Burris,et al.  Clinical development of topoisomerase-interactive drugs. , 1994, Advances in pharmacology.

[7]  B. Gatto,et al.  DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Nakano,et al.  Induction of mammalian DNA topoisomerase I-mediated DNA cleavage and DNA winding by bulgarein. , 1993, The Journal of biological chemistry.

[9]  F. Zunino,et al.  Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects. , 1993, Molecular pharmacology.

[10]  F. Zunino,et al.  Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II. , 1993, Biochemistry.

[11]  T. Ashizawa,et al.  Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives. , 1992, Biochemistry.

[12]  H. Nakano,et al.  Induction of topoisomerase II-mediated DNA cleavage by the plant naphthoquinones plumbagin and shikonin , 1992, Antimicrobial Agents and Chemotherapy.

[13]  K. Kohn,et al.  Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene. , 1992, Cancer research.

[14]  H. Nakano,et al.  Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus. , 1991, Biochemistry.

[15]  H. Nakano,et al.  Induction of a heat-stable topoisomerase II-DNA cleavable complex by nonintercalative terpenoides, terpentecin and clerocidin. , 1991, Cancer research.

[16]  J. Boehm,et al.  Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activity , 1991 .

[17]  H. Nakano,et al.  Saintopin, a new antitumor antibiotic with topoisomerase II dependent DNA cleavage activity, from Paecilomyces. , 1990, The Journal of antibiotics.

[18]  H. Nakano,et al.  Induction of mammalian DNA topoisomerase II dependent DNA cleavage by antitumor antibiotic streptonigrin. , 1990, Cancer research.

[19]  T. Tsuruo,et al.  SYNTHESIS AND ANTITUMOR ACTIVITY OF FUSED TETRACYCLIC QUINOLINE DERIVATIVES , 1990 .

[20]  K. Kohn,et al.  Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II. , 1990, Molecular pharmacology.

[21]  T. Furuta,et al.  Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse. , 1990, Cancer research.

[22]  Yamashita Yoshinori,et al.  Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. , 1990 .

[23]  K. Kohn,et al.  Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicity. , 1990, Biochemistry.

[24]  U. K. Laemmli,et al.  Preferential, cooperative binding of DNA topoisomerase II to scaffold‐associated regions. , 1989, The EMBO journal.

[25]  L. Liu,et al.  DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts. , 1989, Science.

[26]  L. Liu,et al.  Evidence for the reversibility of cellular DNA lesion induced by mammalian topoisomerase II poisons. , 1989, The Journal of biological chemistry.

[27]  T. Tsuruo,et al.  Synthesis and antitumor activity of fused tetracyclic quinoline derivatives. 1. , 1989, Journal of medicinal chemistry.

[28]  K. Kohn,et al.  Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity. , 1989, Cancer research.

[29]  L. Liu,et al.  DNA topoisomerase poisons as antitumor drugs. , 1989, Annual review of biochemistry.

[30]  L. Liu,et al.  Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. , 1988, Cancer research.

[31]  A. Riva,et al.  Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nuclei. , 1987, Cancer research.

[32]  F. Della Seta,et al.  Structure of RNA polymerase II promoters. Conformational alterations and template properties of circularized Saccharomyces cerevisiae GAL1‐GAL10 divergent promoters. , 1986, The EMBO journal.

[33]  L. Liu,et al.  DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II. , 1986, Cancer research.

[34]  R. Hertzberg,et al.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.

[35]  K. Kohn,et al.  Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei. , 1985, Biochemistry.

[36]  S. Crooke,et al.  Application of a tissue culture microtiter test for the detection of cytotoxic agents from natural products. , 1985, The Journal of antibiotics.

[37]  L. Liu,et al.  Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. , 1984, The Journal of biological chemistry.

[38]  L. Liu,et al.  Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. , 1984, Science.

[39]  L. Liu,et al.  Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide. , 1984, Proceedings of the National Academy of Sciences of the United States of America.